Now Reading:
KCI Files Registration Statement for Proposed Initial Public Offering
Full Article 4 minutes read

KCI Files Registration Statement for Proposed Initial Public Offering

SAN ANTONIO–(BUSINESS WIRE)–Acelity announced today that its affiliate, KCI Holdings, Inc. (“KCI”),
filed a registration statement on Form S-1 with the U.S. Securities and
Exchange Commission (“SEC”), relating to a proposed initial public
offering of KCI’s common stock. Prior to the effectiveness of the
registration statement, there will be a restructuring as a result of
which KCI will become the holding company of the businesses currently
conducted by Acelity L.P. Inc. and its subsidiaries. The number of
shares to be offered and the price range for the proposed offering have
not yet been determined.

J.P. Morgan, Goldman Sachs & Co. LLC and BofA Merrill Lynch are acting
as joint book-running managers for the proposed offering.

The offering will be made only by means of a prospectus. When available,
a copy of the preliminary prospectus related to the offering may be
obtained from: J.P. Morgan, Attention: Prospectus Department c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY
11717, via telephone: 1-866-803-9204; Goldman Sachs & Co. LLC,
Attention: Prospectus Department, 200 West Street, New York, NY 10282,
via telephone: 1-866-471-2526 or by facsimile at 212-902-9316, or via
email: prospectus-ny@ny.email.gs.com;
or BofA Merrill Lynch, Attn: Prospectus Department, 200 North College
Street, 3rd Floor, Charlotte, NC 28255-0001, or by email at dg.prospectus_requests@baml.com.

A registration statement relating to these securities has been filed
with the SEC but has not yet become effective. These securities may not
be sold nor may offers to buy be accepted prior to the time the
registration statement becomes effective. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy these
securities, nor shall there be any sale of these securities in any state
or jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities
laws of any such state or jurisdiction.

About Acelity

Acelity L.P. Inc. is a global medical technology company focused on
advanced wound care and specialty surgical applications marketed under
the KCI brand. The KCI product portfolio is available in more than 90
countries. Headquartered in San Antonio, Texas, Acelity employs nearly
5,000 people around the world.

Contacts

Maggie Fairchild
Corporate Communications, Media
Phone:
+1-210-330-2666

Email: maggie.fairchild@acelity.com

David Clair, CFA
Investor Relations
Westwicke
Partners

Phone: +1-646-277-1266
Email: investors@acelity.com

Leave a Reply

Your email address will not be published. Required fields are marked *

Input your search keywords and press Enter.